Cost-effectiveness of the subcutaneous house dust mite allergen immunotherapy plus pharmacotherapy for allergic asthma: A mathematical model

Allergy. 2021 Jul;76(7):2229-2233. doi: 10.1111/all.14723. Epub 2021 Jan 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Dermatophagoides*
  • Asthma* / drug therapy
  • Cost-Benefit Analysis
  • Desensitization, Immunologic
  • Dust
  • Humans
  • Models, Theoretical
  • Pyroglyphidae

Substances

  • Antigens, Dermatophagoides
  • Dust